ctrl K

Price Alert

Oramed Pharmaceuticals In... (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

2.08

-0.04 (-1.89%)

At close: Aug 15, 2025, 3:59 PM

2.07

-0.48%

After-hours: Aug 15, 2025, 05:49 PM EDT

Oramed Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Aug 31, 2021
Cash & Equivalents	9.05M	40.46M	77.25M
Short-Term Investments	152.99M	115.26M	16.89M
Long-Term Investments	56.37M	2.7M	6.69M
Other Long-Term Assets	34K	24K	25.04M
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	537K	1.39M	1.2M
Total Current Assets	162.58M	157.11M	95.34M
Property-Plant & Equipment	1.57M	1.81M	932K
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	57.97M	4.53M	32.66M
Total Assets	220.55M	161.64M	128M
Account Payables	551K	2.17M	2.61M
Deferred Revenue	n/a	1.34M	2.7M
Short-Term Debt	51.01M	247K	130K
Other Current Liabilities	325K	1.98M	1.24M
Total Current Liabilities	53.21M	5.75M	6.68M
Long-Term Debt	n/a	647K	403K
Other Long-Term Liabilities	102K	82K	145K
Total Long-Term Liabilities	4.44M	4.74M	4.8M
Total Liabilities	57.66M	10.49M	11.48M
Total Debt	51.62M	894K	533K
Common Stock	485K	476K	424K
Retained Earnings	-157.56M	-163.08M	-114.85M
Comprehensive Income	n/a	n/a	n/a
Shareholders Equity	163.82M	151.81M	115.77M
Total Investments	207.92M	117.96M	23.59M